Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DATOPOTAMAB DERUXTECAN: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

62.2%
Female
37.8%
Male

Age Information

The average age of patients reporting adverse events with DATOPOTAMAB DERUXTECAN is 62.3 years.

Geographic Distribution

The majority of adverse event reports for DATOPOTAMAB DERUXTECAN originate from US.

Report Summary & Outcomes

52
Total Reports
52
As Primary/Secondary Suspect
24
Deaths Reported
19
Hospitalizations
6
Life-Threatening
2
Disabilities

Reporting Timeline

First adverse event report: 20211231. Most recent report: 20250908. View full timeline →

More About DATOPOTAMAB DERUXTECAN

DATOPOTAMAB DERUXTECAN Full Profile Reports by Year Drug Interactions